Anti-IL-17 monoclonal antibody for induction of remission in Crohn's disease

The primary objectives are to assess the efficacy and safety of IL-17 monoclonal antibody for induction of remission in Crohn's disease.

This is a protocol.

Health topics:

Published:

17 October 2012

Authors:

Zhang S, Li R, Qing Q, Zhang T, Zhou Y, Chen Y, Zhang Y, Lin S, Liu Y

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Zhang S, Li R, Qing Q, Zhang T, Zhou Y, Chen Y, Zhang Y, Lin S, Liu Y. Anti-IL-17 monoclonal antibody for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2012, Issue 10. Art. No.: CD010147. DOI: 10.1002/14651858.CD010147